We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
When Health Catalyst begins working with a hospital system, it makes a sweet offer: Move your engineers over to the Utah-based software firm, and they’ll keep your data running and analyzable it ...
RBC Capital analyst Sean Dodge lowered the firm’s price target on Health Catalyst (HCAT) to $7 from $9 and keeps a Sector Perform rating on the shares. The company’s outlook update included a ...
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living ...
The Fund seeks long-term capital appreciation. The Fund seeks to provide a total return that exceeds the BNP Paribas Catalyst Systematic Alpha Index II (the Benchmark). The Benchmark is an ...